Fig. 3From: Effects of dabigatran versus warfarin on 2-year cognitive outcomes in old patients with atrial fibrillation: results from the GIRAF randomized clinical trialExploratory cognitive outcomes in dabigatran and warfarin groups grouped by cognitive domains. Differences between dabigatran and warfarin treatment groups are depicted from baseline estimates (points) and 95% confidence intervals (segments) in the outcomes grouped by cognitive domainsBack to article page